Abstract
Orbital inflammation is typically an idiopathic process that occasionally may be identified with a specific local or systemic disease as the causative agent. Orbital inflammatory pseudotumor (also known as idiopathic orbital inflammation syndrome, orbital pseudotumor, nonspecific orbital inflammation, and orbital inflammatory syndrome) is defined as an idiopathic tumor-like inflammation consisting of a pleomorphic cellular response and a fibrovascular tissue reaction. Various rheumatologic disorders are associated with orbital inflammation and must be ruled out in cases of orbital inflammatory pseudotumor, including Wegener’s granulomatosis, giant cell arteritis, systemic lupus erythematosus, dermatomyositis, and rheumatoid arthritis. The mainstay of therapy is corticosteroid therapy, although there is an increasing trend toward use of antimetabolites, alkylating agents, cytotoxic agents, and other immunosuppressive agents.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Jacobs D, Galetta S: Diagnosis and management of orbital pseudotumor. Ophthalmology 2002, 13:347–351.
Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L: What is orbital pseudotumor? Surv Ophthalmol 1996, 41:66–78.
Yuen SJA, Rubin PAD: Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin North Am 2002, 15:121–126.
Alshaikh M, Kakakios AM, Kemp AS: Orbital myositis following streptococcal pharyngitis. J Paediatr Child Health 2008, 44:233–234.
Mackie SL, Keat A: Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology 2004, 43:949–954.
Dale RC, Candler PM, Church AJ, et al.: Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 2006, 172:187–197.
Venuta A, Ferrari P, Beverelli A, et al.: Acute post-streptococcal polymyalgia: two new cases with a review of the literature. Eur J Pediatr 1995, 154:475–476.
Nieto JC, Kim N, Lucarelli MJ: Dacryoadenitis and orbital myositis associated with lyme disease. Arch Ophthalmol 2008, 126:1165–1166.
Kawasaki A, Borruat FX: An unusual presentation of herpes zoster ophthalmicus: orbital myositis preceding vesicular eruption. Am J Ophthalmol 2003, 136:574–575.
Badilla J, Dolman P: Orbital myositis involving the oblique muscles associated with herpes zoster ophthalmicus. Ophthal Plast Reconstr Surg 2007, 23:411–413.
Volpe NJ, Shore JW: Orbital myositis associated with herpes zoster. Arch Ophthalmol 1991, 109:471–472.
Sobrin L, Kim E, Christen W, et al.: Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol 2007, 125:895–900.
Garrity JA, Coleman AW, Matteson EL, et al.: Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol 2004, 138:925–930.
Atabay C, Tyutyunikov A, Scalise D, et al.: Serum antibodies reactive with eye muscle membrane antigens are detected in patients with nonspecific orbital inflammation. Ophthalmology 1995, 102:145–153.
Yuen SJA, Rubin PAD: Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003, 121:491–499.
Lanciano R, Fowble B, Sergott RC, et al.: The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys 1990, 18:407–411.
Sergott R, Glaser J, Charyulu K: Radiotherapy for idiopathic inflammatory orbital pseudotumor: indications and results. Arch Ophthalmol 1981, 99:8536.
Orcutt J, Garner A, Henk J, Wright J: Treatment of idiopathic inflammatory orbital pseudotumors by radiotherapy. Br J Ophthalmol 1983, 67:570–574.
Smitt MC, Donaldson SS: Radiation therapy for benign disease of the orbit. Semin Radiat Oncol 1999, 9:179–189.
Zacharopoulos IP, Papadaki T, Manor RS, Briscoe D: Treatment of idiopathic orbital inflammatory disease with cyclosporine-A: a case presentation. Semin Ophthalmol 2009, 24:260–261.
Bielory L, Frohman LP: Low-dose cyclosporine therapy of granulomatous optic neuropathy and orbitopathy. Ophthalmology 1991, 98:1732–1736.
• Buell C, Koo J: Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol 2008, 7:741–748. This was a meta-analysis review of CsA use that examined its safety profile.
Diaz-Llopis M, Menezo JL: Idiopathic inflammatory orbital pseudotumor and low-dose cyclosporine. Am J Ophthalmol 1989, 107:547–548.
Falcini F, Simonini G, Resti M, Cimaz R: Recurrent orbital pain and diplopia in a 12 year old boy. Ann Rheum Dis 2002, 61:93–94.
Sanchez-Roman J, Varela-Aguilar JM, Bravo-Ferrer J, et al.: Idiopathic orbital myositis: treatment with cyclosporin. Ann Rheum Dis 1993, 52:84–85.
• Gumus K, Mirza GE, Cavanagh HD, Karakucuk S: Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature. Eye Contact Lens 2009, 35:275–278. This case report showed topical corticosteroid and CsA use to control orbital inflammation in a patient who did not achieve control and did not tolerate the side effects of oral corticosteroids and oral CsA.
Smith JR, Rosenbaum JT: A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001, 85:1220–1224.
Shah SS, Lowder CY, Schmitt MA, et al.: Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 1992, 99:1419–1423.
Osborne S, Sims JL, Rosser PM: Short-term use of infliximab in a case of recalcitrant idiopathic orbital inflammatory disease. Clin Experiment Ophthalmol 2009, 37:897–900.
• Sahlin S, Lignell B, Williams M, et al.: Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol 2009, 87:906–908. This case report showed successful treatment with infliximab of a very difficult subset of OIP patients.
Miquel T, Abad S, Badelon I, et al.: Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents. Ophthal Plast Reconstr Surg 2008, 24:415–417.
Prendiville C, O’Doherty M, Moriarty P, Cassidy L: The use of infliximab in ocular inflammation. Br J Ophthalmol 2008, 92:823–825.
Wilson MW, Shergy WJ, Haik BG: Infliximab in the treatment of recalcitrant idiopathic orbital inflammation. Ophthal Plast Reconstr Surg 2004, 20:381–383.
Acknowledgment
Dr. Espinoza is partially supported by an unrestricted educational grant from Research to Prevent Blindness.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Espinoza, G.M. Orbital Inflammatory Pseudotumors: Etiology, Differential Diagnosis, and Management. Curr Rheumatol Rep 12, 443–447 (2010). https://doi.org/10.1007/s11926-010-0128-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-010-0128-8